Clinical Trial Update: Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 safety and immunogenicity study of a pentavalent DTwP-HepB-Hib-IPV vaccine in Indonesian infants; the trial is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTwP-HepB-Hib-IPV vaccine (pentavalent diphtheria-tetanus-pertussis-Hepatitis B-Haemophilus influenzae type b- poliovirus vaccine)

Snippet

Sponsor: PT Bio Farma | Conditions: Vaccine Adverse Reaction, Vaccine Reaction | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING